MOLECULIN BIOTECH INC's ticker is MBRX and the CUSIP is 60855D101. A total of 15 filers reported holding MOLECULIN BIOTECH INC in Q4 2017. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $10,000 | -23.1% | 12,000 | 0.0% | 0.00% | – |
| Q3 2019 | $13,000 | +8.3% | 12,000 | +20.0% | 0.00% | – |
| Q2 2019 | $12,000 | -25.0% | 10,000 | -50.0% | 0.00% | – |
| Q1 2019 | $16,000 | +60.0% | 20,000 | +100.0% | 0.00% | – |
| Q4 2018 | $10,000 | -69.7% | 10,000 | -52.4% | 0.00% | – |
| Q3 2018 | $33,000 | -15.4% | 21,000 | -4.5% | 0.00% | – |
| Q2 2018 | $39,000 | +34.5% | 22,000 | +33.3% | 0.00% | – |
| Q1 2018 | $29,000 | 0.0% | 16,500 | +7.1% | 0.00% | – |
| Q4 2017 | $29,000 | – | 15,400 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Acrospire Investment Management LLC | 1,600 | $9,000 | 0.01% |
| Virtu KCG Holdings LLC | 11,614 | $66,000 | 0.00% |
| ING GROEP NV | 20,000 | $122,000 | 0.00% |
| NEXT Financial Group, Inc | 500 | $3,000 | 0.00% |
| Tower Research Capital LLC (TRC) | 917 | $5,000 | 0.00% |
| CITIGROUP INC | 5,000 | $29,000 | 0.00% |
| MORGAN STANLEY | 700 | $4,000 | 0.00% |
| WFG Advisors, LP | 400 | $2,000 | 0.00% |
| UBS Group AG | 2,495 | $14,000 | 0.00% |